Lorenzo Volpicelli | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
A role for ceftazidime/avibactam combination therapy. The question may still be on the table	INFECTION	2024
Real-world use of imipenem/cilastatin/relebactam for the treatment of KPC-producing Klebsiella pneumoniae complex and difficult-to-treat resistance (DTR) Pseudomonas aeruginosa infections. A single-center preliminary experience	FRONTIERS IN MICROBIOLOGY	2024
Simultaneous post-neurosurgical ventriculitis and bacteraemia by two different strains of KPC-producing K. pneumoniae successfully treated with meropenem/vaborbactam and high dose of fosfomycin	JAC-ANTIMICROBIAL RESISTANCE	2024
Impact of renal-adjusted ceftazidime/avibactam in patients with KPC-producing K. pneumoniae bloodstream infection: a retrospective cohort study	JAC-ANTIMICROBIAL RESISTANCE	2024
Clinical characteristics and outcome of ceftazidime/avibactam-resistant Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae infections. A retrospective, observational, 2-center clinical study	OPEN FORUM INFECTIOUS DISEASES	2023
Evaluation of the factors associated with reinfections towards SARS-CoV-2 using a case control design	JOURNAL OF CLINICAL MEDICINE	2023
Acute bacterial skin and skin structure infections in pediatric patients: potential role of dalbavancin	EXPERT REVIEW OF ANTI-INFECTIVE THERAPY	2023
Ceftazidime/avibactam-resistant meropenem-susceptible KPC-producing Klebsiella pneumoniae: Analysis of cases and evaluation of in vitro activity of fosfomycin-containing combinations	JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE	2023
New Antimicrobials and New Therapy Strategies for Endocarditis: Weapons That Should Be Defended	JOURNAL OF CLINICAL MEDICINE	2023
Did the updated Duke criteria missed Erysipelothrix rhusiopathiae from the list of typical microorganisms causing infective endocarditis?	LE INFEZIONI IN MEDICINA	2023
An outbreak sustained by ST15 Klebsiella pneumoniae carrying 16S rRNA methyltransferases and blaNDM: evaluation of the global dissemination of these resistance determinants	INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS	2022
Clinical course of Coronavirus Disease-19 in patients with haematological malignancies is characterized by a longer time to respiratory deterioration compared to non-haematological ones: results from a case-control study	INFECTION	2022
Impact of pre-existent drug resistance on virological efficacy of single-tablet regimens in people living with HIV	INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS	2022
Risk of Seven-Day Worsening and Death: A New Clinically Derived COVID-19 Score	VIRUSES	2022
Effect of ceftazidime/avibactam plus fosfomycin combination on 30 day mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae. Results from a multicentre retrospective study	JAC-ANTIMICROBIAL RESISTANCE	2022
Correction: Clinical course of Coronavirus Disease-19 in patients with haematological malignancies is characterized by a longer time to respiratory deterioration compared to non-haematological ones: results from a case–control study	INFECTION	2022
Correction: Clinical course of Coronavirus Disease-19 in patients with haematological malignancies is characterized by a longer time to respiratory deterioration compared to non-haematological ones: results from a case–control study (Infection, (2022), 50, 5, (1373-1382), 10.1007/s15010-022-01869-w)	INFECTION	2022
Synergistic Meropenem/Vaborbactam Plus Fosfomycin Treatment of KPC Producing K. pneumoniae Septic Thrombosis Unresponsive to Ceftazidime/Avibactam: From the Bench to the Bedside	ANTIBIOTICS	2021
The role of combination therapy in critically Ill patients with methicillin-susceptible staphylococcus aureus bloodstream infections. Does the question remain?	CLINICAL INFECTIOUS DISEASES	2021
Place in Therapy of the Newly Available Armamentarium for Multi-Drug-Resistant Gram-Negative Pathogens: Proposal of a Prescription Algorithm	ANTIBIOTICS	2021